News & Insights

• Oxehealth Ltd is commercialising world-leading clinically-validated remote patient monitoring technology.
• OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a £5m round led by existing shareholders.
• This is third OTIF investment in Oxehealth Ltd to date, bringing total funds invested by OTIF in the Company to £800,013.

The Start-up Rescue Instrument gives a total of €5.5m in co-investment to help companies maintain business continuity

We’re proud to announce that Caristo Diagnostics Ltd and Oxford Brain Diagnostics Ltd, have both been shortlisted for the inaugural 2020 Nature Spinoff Prize.

We’re hosting a live webinar with OTIF portfolio company Caristo Diagnostics on Wednesday 24^th June 2020 at 17:30

We’re hosting a live webinar with OTIF portfolio company OxSonics on Wednesday 27^th May 2020 at 10:00 am